BHP Share price forecast: What’s ahead for the company in 2024 and 2025?
The stock market is always full of surprises, with BHP Group Limited (ASX: BHP) capturing plenty of attention lately. In…
Carbon neutral investing: Here’s what curious investors need to know and which stocks they might easily consider
As the world seeks to reduce carbon emissions, carbon neutral investing might be a strategy for investors to consider. But…
Best Nifty Stocks to Buy in June 2024
As we step into June 2024, the Indian stock market is truly a hotspot for investors looking to make their…
Nifty Prediction Before Election Results 2024: What to Expect on June 4
The buzz among market analysts is palpable as exit polls signal yet another win for Prime Minister Narendra Modi in…
Modi Stocks: Here are the best stocks to buy after the Indian election in 2024
Let’s take a look at so-called Modi stocks; in other words, stocks to buy after the Indian election. India may…
Director Trades: Are they a good or bad sign? Here’s what investors should read into them
Director trades – either purchases or sales – are taken by investors as a sign of confidence (or a lack…
Oracle Corporation (NYSE:ORCL): Its 50% more valuable than Adobe and double IBM! Why the high price tag?
Oracle Corporation (NYSE:OCL) is one of the world’s largest software companies. Capped at $340.1bn, it is not one of the…
Australia’s Housing Crisis is Worsening, but Savvy Investors can Benefit in 2024
The Housing Crisis is not just about problems Australia’s housing market is at a turning point. We’re seeing a serious…
Here’s why founder-led companies can be good investments, or the odd man out!
Some companies on stock exchanges are founder-led companies. For several reasons, a company being founder-led can be a sign of…
Here are the 4 best ASX stocks for June 2024
Here are the 4 best ASX stocks for June 2024! Each month, we look at the best ASX stocks of…
Dimerix (ASX:DXB) just closed a 2nd licensing deal
Dimerix (ASX:DXB) did it again ASX-listed kidney disease drug developer Dimerix (ASX: DXB) is well positioned to bring its DMX-200…
James Hardie (ASX:JHX): Things have turned glum and there could be worse to come, but are fears overblown?
James Hardie (ASX:JHX) is one of the companies many would struggle to have sympathy for. It had a tortured history…
BHP wanted to buy Anglo American, but not even A$75bn could get the deal over the line
Nearly a month since it was made clear BHP wanted to buy Anglo American, it seems the deal is off.…
Orphan Drug Designation: What is it and why is it a big deal for biotech stocks?
While most small cap health stocks dream of commercialisation, healthcare companies at an early stage get excited about achieving Orphan…
Will the RBA Cut Interest Rates in 2024 and, if So, Which Stocks Should I Buy?
The Reserve Bank of Australia (RBA) has been a focal point of economic discussions in 2024. With the cash rate…